GlassScriptPhysician profile
Heather Grace Hoffmann
NPI 1568098184
$1,104.85
in general payments reported to CMS, 2019-2025
19 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $40.60 · 2022: $155 · 2023: $654 · 2024: $97.55 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $910.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $909.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $185.41 | 2023-2025 | Breztri, Fasenra, Tezspire |
| Glaxosmithkline, LLC. | $184.05 | 2022-2025 | Nucala, Trelegy Ellipta |
| Pharmacyclics LLC, An Abbvie Company | $119.78 | 2022 | |
| Ethicon INC. | $110.80 | 2023 | Monarch Platform |
| Genzyme Corporation | $98.71 | 2023-2024 | |
| Genentech USA, INC. | $73.43 | 2023 | Xolair, Venclexta |
| Inogen, INC. | $41.34 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.52 | 2023-2024 | Ofev |
| Novartis Pharmaceuticals Corporation | $34.29 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $32.88 | 2023 | |
| Pulmonx Corporation | $29.04 | 2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Takeda Pharmaceuticals U.S.A., INC. | $27.19 | 2021 | |
| Morphosys, US INC. | $24.29 | 2023 | Monjuvi |
| Baxter Healthcare | $19.63 | 2023 | Hillrom - Life 2000 Ventilation System |
| Pharmaessentia USA Corporation | $19.15 | 2023 | Besremi |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adc Therapeutics America, INC. | $17.99 | 2022 | |
| Insmed, INC. | $17.79 | 2025 | Brinsupri, Arikayce |
| Lilly USA, LLC | $16.03 | 2023 | Verzenio, Retevmo, Jaypirca |
| Jazz Pharmaceuticals INC. | $14.53 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Hoffmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.